We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
-7.16%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$168M
AUM Growth
-$60.4M
Cap. Flow
-$2.18M
Cap. Flow %
-1.3%
Top 10 Hldgs %
50.46%
Holding
90
New
22
Increased
16
Reduced
21
Closed
14

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.54M
2
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$2.46M
3
NFLX icon
Netflix
NFLX
+$1.73M
4
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$1.72M
5
ET icon
Energy Transfer Partners
ET
+$1.01M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.09M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.99M
3
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$1.81M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.18M

Sector Composition

Rank Sector Weight
1 Healthcare 43.12%
2 Miscellaneous 25.18%
3 Technology 13.36%
4 Communication Services 7.77%
5 Financials 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
76
CALL
Cisco
CSCO
$438B
– –
-5,000
Closed -$279K
DIS icon
77
Walt Disney
DIS
$183B
– –
-4,000
Closed -$549K
ITW icon
78
Illinois Tool Works
ITW
$75.9B
– –
-5,075
Closed -$1.06M
KRE icon
79
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.25B
– –
-5,000
Closed -$345K
KRE icon
80
State Street SPDR S&P Regional Banking ETF
KRE
$4.25B
– –
-7,500
Closed -$517K
LCTX icon
81
Lineage Cell Therapeutics
LCTX
$266M
– –
-53,000
Closed -$82K
NKTR icon
82
Nektar Therapeutics
NKTR
$2.34B
– –
-1,000
Closed -$81K
PRTA icon
83
CALL
Prothena Corp
PRTA
$438M
– –
-2,500
Closed -$91K
REGN icon
84
PUT
Regeneron Pharmaceuticals
REGN
$80.3B
– –
-3,000
Closed -$2.1M
SOFI icon
85
SoFi Technologies
SOFI
$21.7B
– –
-45,000
Closed -$425K
SPY icon
86
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$803B
– –
-10,000
Closed -$4.52M
SPY icon
87
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$803B
– –
-24,500
Closed -$11.1M
TSM icon
88
TSMC
TSM
$2.2T
– –
-9,000
Closed -$938K
XLP icon
89
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
– –
-9,000
Closed -$683K
1 2 3
4

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, DCF Advisers held 90 positions worth $168M, down 26% from $228M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers's Q2 2022 filing shows 22 new, 16 increased, 21 reduced and 14 closed positions. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 17,500 shares worth $2.09M. The largest sale was AbbVie, an estimated $2.09M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 35% a quarter earlier, followed by Miscellaneous and Technology.

  • DCF Advisers's largest Q2 2022 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 17,500 shares worth $2.09M.
  • DCF Advisers added most to Apple in Q2 2022, an estimated $2.54M increase.
  • DCF Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $2.09M.
  • DCF Advisers fully exited Illinois Tool Works in Q2 2022, selling an estimated $1.06M.
  • DCF Advisers's ten largest holdings make up 50% of its $168M portfolio in Q2 2022.
  • DCF Advisers opened 22 new positions and closed 14 in Q2 2022.
  • DCF Advisers's portfolio value fell 26% quarter-over-quarter to $168M.

Based on DCF Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.